L. Kircik, “Roflumilast Cream (ARQ-151) 0.15% and 0.3% Improved Burden of Signs and Symptoms in Adults With Chronic Plaque Psoriasis in a Phase 2b Study”, J of Skin, vol. 4, no. 6, p. s70, Oct. 2020.